86 results on '"Meijer, Chris J.L.M."'
Search Results
2. Management of HPV-positive women in cervical screening using results from two consecutive screening rounds
3. Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population
4. Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancer
5. Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up
6. Anal HPV 16 and 18 viral load: A comparison between HIV-negative and -positive MSM and association with persistence
7. Stratifying HPV-positive women for CIN3+ risk after one and two rounds of HPV-based screening
8. Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN
9. The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples
10. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high‐risk HPV‐positive women of a gynecologic outpatient population (COMETH study)
11. CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies
12. Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended?
13. Triaging HPV‐positive women with normal cytology by p16/Ki‐67 dual‐stained cytology testing: Baseline and longitudinal data
14. Early detection of CIN3 and cervical cancer during long-term follow-up using HPV/Pap smear co-testing and risk-adapted follow-up in a locally organised screening programme
15. Review: Current knowledge on the role of HPV antibodies after natural infection and vaccination: Implications for monitoring an HPV vaccination programme
16. CADM1andMALpromoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease
17. Comparison of HPV DNA testing in cervical exfoliated cells and tissue biopsies among HIV-positive women in Kenya
18. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm
19. High-risk HPV testing on self-sampledversusclinician-collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening
20. Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran
21. Chromosomal profiles of high-grade cervical intraepithelial neoplasia relate to duration of preceding high-risk human papillomavirus infection
22. Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa
23. Male circumcision is associated with a lower prevalence of human papillomavirus-associated penile lesions among Kenyan men
24. Experience with high‐risk human papillomavirus testing on vaginal brush‐based self‐samples of non‐attendees of the cervical screening program
25. Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening
26. Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women
27. Human papillomavirus infection in a population-based sample of women in Algiers, Algeria
28. Methods for HPV detection in exfoliated cell and tissue specimens
29. Prevalence and risk factors of human papillomavirus infection by penile site in uncircumcised Kenyan men
30. Human papillomavirus in early laryngeal carcinoma
31. HPV16/18 vaccination to prevent cervical cancer in The Netherlands: Model-based cost-effectiveness
32. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
33. High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer
34. Comparison of HPV and cytology triage algorithms for women with borderline or mild dyskaryosis in population-based cervical screening (VUSA-screen study)
35. Post‐treatment CIN: Randomised clinical trial using hrHPV testing for prediction of residual/recurrent disease
36. Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression
37. Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer
38. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer
39. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen
40. Risk of high‐grade cervical intra‐epithelial neoplasia based on cytology and high‐risk HPV testing at baseline and at 6‐months
41. Human papillomavirus testing on self-sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs
42. CD4+CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia
43. Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation
44. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay
45. Overview of the European and North American studies on HPV testing in primary cervical cancer screening
46. Flat penile lesions: The infectious “invisible” link in the transmission of human papillomavirus
47. Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology
48. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival
49. A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening
50. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.